Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Status and phase
Conditions
Treatments
Details and patient eligibility
About
The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.
Sex
Ages
Volunteers
Inclusion criteria
- Surgical diagnosis of endometriosis within 5 years
- Not pregnant and not lactating
- Willing to use non-hormonal contraception, history of regular menstrual cycles
Exclusion criteria
- Hysterectomy, surgical treatment for endometriosis within 3 months
- Certain medications for the treatment of endometriosis
- Previous history of a malignancy
- Abnormalities on physical or gyn exams and abnormal lab tests
Trial design
Primary purpose
Allocation
Interventional model
Masking
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal